May 23, 2010
Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer [ PDF ]

September 2, 2009
Quanterix Corporation Announces the Appointment of Dr. David Okrongly to CEO [ PDF ]

November 11, 2008
Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board [ PDF ]

September 30, 2008
Quanterix Corporation Awarded $185,000 Grant from the National Cancer Institute [ PDF ]

August 25, 2008
Quanterix Corporation Raises $15 Million in Series A Financing [ PDF ]

July/August 2010
Quanterix Corporate Profile Featured in Start-Up Magazine

June 3, 2010
Quanterix featured in the MIT Technology Review “Detecting Single Cancer Molecules”

January 19, 2010
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood

May 13, 2008
Quanterix featured in the MIT Technology Review “Next Generation Diagnostics”

April 4, 2008
Editors’ Choice in Science magazine. “Distinctive Individualism” highlights enzymatic heterogeneity observed at the single molecule level.
To learn more about this research, click here.